For injectable formulations, there is no requirement to eat at any specific time relative to injection
And the STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program provides the most robust dataset available for understanding semaglutide results over time
Poster Title: Trends in Guideline-Directed Medical Therapy frorType 2 Diabetes in a Statewide Quality Collaborative Between 2018-2023 Authors: Kara Mizokami-Stout, MD [1,2] Katherine L
Depending on provider evaluation and when clinically appropriate, some patients may discuss alternative treatment options, including Wegovy, Mounjaro, Zepbound, tirzepatide-based therapies, or other physician-guided weight management approaches
Developed by Novo Nordisk, Ozempic aids in glycemic control and offers the dual benefit of potential weight loss for individuals managing this chronic condition